Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome

INTRODUCTION: The present study was undertaken to elucidate the expression status and molecular mechanism underlying microRNA-3127-5p (miR-3127-5p) in polycystic ovary syndrome (PCOS). MATERIAL AND METHODS: A total of 50 PCOS and 50 non-PCOS patients were recruited as research subjects. Quantitative...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjuan Zhang, Ling Peng, Lei Yao
Format: Article
Language:English
Published: Via Medica 2025-08-01
Series:Endokrynologia Polska
Subjects:
Online Access:https://journals.viamedica.pl/endokrynologia_polska/article/view/104875
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849230255372369920
author Hongjuan Zhang
Ling Peng
Lei Yao
author_facet Hongjuan Zhang
Ling Peng
Lei Yao
author_sort Hongjuan Zhang
collection DOAJ
description INTRODUCTION: The present study was undertaken to elucidate the expression status and molecular mechanism underlying microRNA-3127-5p (miR-3127-5p) in polycystic ovary syndrome (PCOS). MATERIAL AND METHODS: A total of 50 PCOS and 50 non-PCOS patients were recruited as research subjects. Quantitative real-time polymerase chain reaction was employed to assess the relative abundances of miR-3127-5p in serum, cumulus cells (CCs), and granulosa cells (GCs) from PCOS patients. Additionally, cellular activities and ferroptosis-related biomarkers were evaluated. Bioinformatics analysis was conducted to identify potential targets of miR-3127-5p. To validate the interaction between miR-3127-5p and sorbin and SH3 domain-containing protein 1 (SORBS1), a luciferase reporter assay was conducted. RESULTS: Enforced miR-3127-5p expression was detected in serum, CCs, and GCs from PCOS patients, demonstrating a robust diagnostic capacity for effectively distinguishing between PCOS and non-PCOS patients. Furthermore, the reduction of miR-3127-5p expression was found to enhance cell viability and inhibit cell apoptosis in human granulosa-like tumor cell line (KGN) and the luteinized granulosa cell line (SVOG) cells. Concurrently, its down-regulation led to attenuated levels of iron, malondialdehyde (MDA), and reactive oxygen species (ROS), while simultaneously increasing the expression of glutathione peroxidase 4 (GPX4). Notably, miR-3127-5p expression exhibited an inverse relationship with SORBS1. Rescue experiments revealed that the effects of downregulated miR-3127-5p expression on cellular behaviors and ferroptosis were reserved through the transfection of si-SORBS1. CONCLUSION: The downregulation of miR-3127-5p expression facilitates cell growth and attenuates ferroptosis by targeting SORBS1, thereby playing a pivotal role in the initiation and development of PCOS.
format Article
id doaj-art-bb1d34d0c6d84f52859cf6bf5d4924c6
institution Kabale University
issn 0423-104X
2299-8306
language English
publishDate 2025-08-01
publisher Via Medica
record_format Article
series Endokrynologia Polska
spelling doaj-art-bb1d34d0c6d84f52859cf6bf5d4924c62025-08-21T06:40:59ZengVia MedicaEndokrynologia Polska0423-104X2299-83062025-08-0176410.5603/ep.104875Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndromeHongjuan Zhang0Ling Peng1Lei Yao2Department of Gynecology, The Fourth Hospital of Shijiazhuang, Shijiazhuang, ChinaDepartment of Gynecology, Chongqing Public Health Medical Center, Chongqing, ChinaDepartment of Gynecology, Geriatric Hospital Affiliated with Wuhan University of Science and Technology, Wuhan, ChinaINTRODUCTION: The present study was undertaken to elucidate the expression status and molecular mechanism underlying microRNA-3127-5p (miR-3127-5p) in polycystic ovary syndrome (PCOS). MATERIAL AND METHODS: A total of 50 PCOS and 50 non-PCOS patients were recruited as research subjects. Quantitative real-time polymerase chain reaction was employed to assess the relative abundances of miR-3127-5p in serum, cumulus cells (CCs), and granulosa cells (GCs) from PCOS patients. Additionally, cellular activities and ferroptosis-related biomarkers were evaluated. Bioinformatics analysis was conducted to identify potential targets of miR-3127-5p. To validate the interaction between miR-3127-5p and sorbin and SH3 domain-containing protein 1 (SORBS1), a luciferase reporter assay was conducted. RESULTS: Enforced miR-3127-5p expression was detected in serum, CCs, and GCs from PCOS patients, demonstrating a robust diagnostic capacity for effectively distinguishing between PCOS and non-PCOS patients. Furthermore, the reduction of miR-3127-5p expression was found to enhance cell viability and inhibit cell apoptosis in human granulosa-like tumor cell line (KGN) and the luteinized granulosa cell line (SVOG) cells. Concurrently, its down-regulation led to attenuated levels of iron, malondialdehyde (MDA), and reactive oxygen species (ROS), while simultaneously increasing the expression of glutathione peroxidase 4 (GPX4). Notably, miR-3127-5p expression exhibited an inverse relationship with SORBS1. Rescue experiments revealed that the effects of downregulated miR-3127-5p expression on cellular behaviors and ferroptosis were reserved through the transfection of si-SORBS1. CONCLUSION: The downregulation of miR-3127-5p expression facilitates cell growth and attenuates ferroptosis by targeting SORBS1, thereby playing a pivotal role in the initiation and development of PCOS.https://journals.viamedica.pl/endokrynologia_polska/article/view/104875MiR-3127-5ppolycystic ovary syndromecellular activitiesferroptosis
spellingShingle Hongjuan Zhang
Ling Peng
Lei Yao
Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
Endokrynologia Polska
MiR-3127-5p
polycystic ovary syndrome
cellular activities
ferroptosis
title Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
title_full Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
title_fullStr Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
title_full_unstemmed Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
title_short Differential expression of microRNA-3127-5p and its molecular mechanisms in polycystic ovary syndrome
title_sort differential expression of microrna 3127 5p and its molecular mechanisms in polycystic ovary syndrome
topic MiR-3127-5p
polycystic ovary syndrome
cellular activities
ferroptosis
url https://journals.viamedica.pl/endokrynologia_polska/article/view/104875
work_keys_str_mv AT hongjuanzhang differentialexpressionofmicrorna31275panditsmolecularmechanismsinpolycysticovarysyndrome
AT lingpeng differentialexpressionofmicrorna31275panditsmolecularmechanismsinpolycysticovarysyndrome
AT leiyao differentialexpressionofmicrorna31275panditsmolecularmechanismsinpolycysticovarysyndrome